Merck KGaA Logo

Merck KGaA

A science & tech firm in healthcare, life science, and electronics, advancing human progress.

6MK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 East Lincoln Avenue, 07065-1310 Rahway
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck KGaA is a leading science and technology company that operates across Healthcare, Life Science, and Electronics. The Healthcare division discovers, develops, and manufactures prescription drugs and therapies for conditions such as cancer, multiple sclerosis, and infertility. The Life Science business collaborates with the global scientific community, providing tools and services to solve complex problems in research and biotech production. Its Electronics division supplies specialty chemicals and materials for demanding applications. Founded in 1668, Merck KGaA is the world's oldest operating chemical and pharmaceutical company, leveraging a long history of research and innovation to advance technology and improve lives.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Interim Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-07 11:28
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-04 13:25
Declaration of Voting Results & Voting Rights Announcements
English 81.3 KB
2025-07-03 10:58
Declaration of Voting Results & Voting Rights Announcements
English 75.7 KB
2025-06-13 15:37
Major Shareholding Notification
English 12.2 KB
2025-06-13 13:23
Declaration of Voting Results & Voting Rights Announcements
English 13.3 KB
2025-06-10 10:31
Declaration of Voting Results & Voting Rights Announcements
English 78.1 KB
2025-06-05 08:43
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-05-19 00:00
Quarterly Report
Q1 statement / Q1 financial report 2025
English 809.0 KB
2025-05-06 13:33
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB
2025-04-26 14:13
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB

Automate Your Workflow. Get a real-time feed of all Merck KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Merck KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway ULTI
Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia SKF
Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo
Develops and distributes prescription & consumer healthcare products in Europe and Asia.
Japan 4559
株式会社PRISM BioLab Logo
A biotech creating novel drugs by targeting previously "undruggable" protein interactions.
Japan 206A

Talk to a Data Expert

Have a question? We'll get back to you promptly.